close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about edit

Recent news which mentions edit

< Previous 1 2 3 4 5 6 7 8 9 Next >
Earnings Scheduled For November 3, 2023
Tickers ACRE AMCX ARQT ASIX
Tags FLR ARQT Market News
From Benzinga
A Preview Of Editas Medicine's Earnings
Tickers EDIT
Tags Market News Benzinga BZI/EP
From Benzinga
Sent Your Boss The Message Meant For Your Girlfriend On Instagram — Now You Can Save Your Bacon
Tickers EDIT META TECH X
Tags Software &amp; Apps News META
From Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
Tickers AMGN BLUE CRSP EDIT
Tags Market News VRTX BLUE
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Tickers ABNB ALKS AMZN ANL
Tags MKFG HR CLPT
From Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
Tickers BEAM CRSP EDIT GNOM
Tags BEAM VRTX NTLA
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
Tickers ALB ALPN ARM BIP
Tags VSTS BNL WLK
From Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
Tickers BEAM EDIT
Tags EDIT BEAM Market News
From Motley Fool
Analyst Ratings for Editas Medicine
Tickers EDIT
Tags Market News Benzinga Analyst Ratings
From Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
Tickers BLUE CRSP EDIT
Tags BLUE News General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Tickers ACA ACAD ACDC ACLX
Tags LEN Market News XOM
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Tickers AHG AMAM ARDX EDIT
Tags TPST NKGN WH
From InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers AMAM EDIT ERIC NOK
Tags Markets Trading Ideas ERIC
From Benzinga
Is Editas Stock a Buy Now?
Tickers EDIT
Tags EDIT Market News Recent Press Releases
From Motley Fool
Avoid Big Losses With Biotech Stocks by Paying Attention to These 2 Things
Tickers EDIT
Tags Market News Recent Press Releases EDIT
From Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
Tickers CRSP EDIT
Tags Recent Press Releases CRSP Market News
From Motley Fool
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers ADD APRN ASTI BCLI
Tags FNGR WAVD Trading Ideas
From Benzinga
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
Tickers CRSP EDIT
Tags EDIT Biotech Analyst Color
From Benzinga
Why Editas Medicine Stock Is Soaring Today
Tickers CRSP EDIT SF VRTX
Tags EDIT SF CRSP
From Motley Fool
Expert Ratings for Editas Medicine
Tickers EDIT
Tags BZI/AAR EDIT Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Tickers ABBV ADBE ADSK AKAM
Tags NICE CUBI OPEN
From Benzinga
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Tickers ACN DPZ EDIT FEMY
Tags NKE ACN Price Target
From Benzinga
Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Tickers BMBL BROG EDIT FOLD
Tags Market News OPK Top Gainers
From Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers AA AGRI ALEC AVTX
Tags Internet Software & Services IHT EGLX
From Benzinga
1 Gene Editing Stock to Buy Now, and 1 to Sell
Tickers CRBU EDIT
Tags Recent Press Releases Market News CRBU
From Motley Fool
Analyst Expectations for Editas Medicine's Future
Tickers EDIT
Tags Benzinga Market News Analyst Ratings
From Benzinga
These 2 Stocks Could Skyrocket by 54% and 119%, According to Wall Street
Tickers EDIT NTLA
Tags NTLA Market News Recent Press Releases
From Motley Fool
Expert Ratings for Editas Medicine
Tickers EDIT
Tags BZI/AAR EDIT Market News
From Benzinga
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks
Tickers BLUE CRSP EDIT NTLA
Tags BLUE EDIT NTLA
From Motley Fool
Is Editas Medicine Stock a Buy Now?
Tickers EDIT
Tags Market News Recent Press Releases EDIT
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today